Hospital Universitari Vall d'Hebron-Departamento de Oncologia- VHIO ( Site 2500)

Barcelona 08035

0 studies enrolling now · 1 studies all time

What they study most

Cervical Cancer

Studies at this site

• A Study to Compare Sacituzumab Tirumotecan (MK-2870) Monotherapy Versus Treatment of Physician's Choice as Second-line Treatment for Participants With Recurrent or Metastatic Cervical Cancer (MK-2870-020/TroFuse-020/Gog-3101/ENGOT-cx20) — Running, not enrolling